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Abstract  
Objective To establish normative values and reference equations of the 6-minute walk test 
(6MWT), incremental shuttle walk test (ISWT) and unsupported upper limb exercise test 













Design Cross-sectional study. Descriptive statistics and differences between age decades and 
genders were explored using univariate general linear models to compute reference values. 
Reference equations were established with a forward stepwise multiple regression. 
Setting General community. 
Participants In total, 645 adult volunteers without disabilities [43% male, mean age 55.1 
(standard deviation 23.6) years] were recruited from the university campus and surrounding 
community.  
Intervention Not applicable. 
Main outcome measures Data on age, gender, height, weight, body mass index and smoking 
status were collected using a structured questionnaire. Physical activity was evaluated using 
the Brief Physical Activity Assessment Tool. Participants performed two repetitions of the 
6MWT, ISWT and UULEX, and the best repetition was used for analysis.  
Results Overall, performance was better in males than in females, and decreased with age. 
Participants’ performance was significantly reduced after the sixth decade of life compared 
with the other decades (P<0.001). Reference equations were: 6MWT=226.93-
(5.00×age)+(360.41×height), R2=71%; ISWT=393.81-
(17.98×age)+(185.64×gender)+(775.88×height), R2=83%; and UULEX=16.71-
(0.14×age)+(2.66×gender), R2=57%. 
Conclusion Leg or arm exercise field tests are affected significantly by age and gender. These 
results will aid health professionals to interpret the results of field tests obtained from healthy 
or diseased adult populations. 
 















Cardiorespiratory fitness (CRF), also known as aerobic fitness or maximal aerobic power, is 
defined as the maximum amount of oxygen that can be taken in, transported to and utilised by 
working tissue during dynamically strenuous exercise involving large muscle mass [1]. 
A growing body of epidemiological and clinical evidence from the past two decades 
[2,3] demonstrates that CRF is a more powerful predictor of risk for adverse outcomes (e.g. 
cardiovascular diseases, cancer and all-cause mortality) than established risk factors, including 
hypertension, lipid abnormalities, smoking, physical inactivity, obesity and diabetes mellitus 
[4,5]. For these reasons, since 2016, CRF has been acknowledged by the American Heart 
Association as the fifth vital sign, and it should be included in patients’ clinical routine 
assessments [6]. 
Maximum oxygen consumption is widely recognised as one of the best indices to 
measure CRF capacity [3], and it can be measured objectively and reliably during 
cardiopulmonary maximal exercise testing. However, this maximal test is expensive, time 
consuming, and requires the use of sophisticated equipment and trained evaluators [3,7]. Thus, 
its use in primary care centres (community-based and private practices), where most routine 
clinical appointments take place, is limited. 
Field tests, including the 6-minute walk test (6MWT), the incremental shuttle walk test 
(ISWT) and the unsupported upper limb exercise test (UULEX), have emerged as suitable 
alternatives to assess CRF [8,9]. The 6MWT and ISWT are frequently used in clinical practice 
to assess exercise capacity in patients with chronic diseases [10]. Although less commonly 
reported, the UULEX has already shown significant correlation with arm ergometry (r≥0.64, 
P<0.05) [11], and thus has been used to determine arm exercise capacity in patients where this 
function is compromised (e.g. patients with chronic obstructive pulmonary disease) [11,12]. 
All three of these field tests have been shown to be reliable, valid and responsive measures of 













Cardiorespiratory field tests are easier to implement than cardiopulmonary maximal 
exercise tests, but their interpretation relies on comparisons with normative data or reference 
equations generated from data of healthy populations [16,17]. Normative and reference data 
aim to characterise a defined population at a specific point or period of time, and have been 
considered essential to describe the natural history of clinical conditions [18], evaluate and 
compare an individual’s performance within a population, establish comparisons between 
different clinical conditions, and evaluate the effectiveness of interventions [19]. It is known 
that normative data and reference equations are population specific, as population 
characteristics (e.g., height, weight, lifestyles) vary across countries, and may affect 
performance in cardiorespiratory field tests [6,20]. Specifically, according to the World Health 
Organization, body mass index (BMI), physical activity (PA) and smoking status differ 
considerably between continents and between countries within the same continent [18,21–23]. 
Since anthropometric and lifestyle health-related data are commonly part of the existing 
reference equations [10], it is expected that equations developed in a given population are not 
generalisable worldwide. Thus, the European Respiratory Society and the American Thoracic 
Society have emphasised the need to produce reference values for different countries [8]. To 
the authors’ knowledge, no study to date has investigated normative values and/or reference 
equations for CRF during lower and upper limb exercise field tests in the Portuguese adult 
population. Therefore, the absence of these data hampers the interpretation of these tests, which 
will, ultimately, prevent health professionals from identifying people with lower CRF and 
prescribing adequate cardiorespiratory exercise training. 
This study aimed to establish the Portuguese adult normative values and reference 















<A>Materials and methods 
<B>Study design 
A cross-sectional study was conducted between September 2012 and September 2017 in people 
without disabilities. Before data collection, the Ethical Committee of the Health Sciences 
Research Unit, [name of city - omitted for blinding purposes], Portugal approved the study, 
and all participants signed an informed consent form. 
 
<B>Participants 
The study was advertised for people without disabilities aged >18 years at the university 
campus and surrounding areas (e.g. fitness centres, community centres, senior universities). 
Posters, flyers and the university and research websites were used for advertisement, so 
interested participants could contact the research team directly. In order to achieve maximum 
representativeness from community-dwelling people, people with the most prevalent age-
related conditions, such as controlled hypertension, hypercholesterolaemia and diabetes, were 
included in the study [24]. This is in accordance with the World Health Organization’s 
definition of ‘health’ as a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity [25]. Exclusion criteria were the presence of one or 
more of the following conditions: acute (within the past month) or chronic respiratory disease, 
cardiac disease, signs of cognitive or neuromuscular impairment, and significant 
musculoskeletal disorder (e.g. kyphoscoliosis) that could interfere with the ability to perform 
the lower and upper limb exercise field tests. For walking tests, subjects using walking aids 















Sociodemographic (age and gender), anthropometric (weight and height measurements to 
compute BMI) and clinical (smoking status, comorbidities and PA) data were collected. 
Smoking status was evaluated through a survey on current or previous smoking habits. The 
severity of comorbid diseases was recorded and scored according to the Charlson Comorbidity 
Index (CCI), and subjects were divided into four groups: CCI score of 0, 1 to 2, 3 to 4, and ≥5 
[26]. PA was assessed using the Brief PA Assessment Tool [27], which consists of two 
questions assessing the frequency and duration of moderate and vigorous PA undertaken in a 
usual week. A total score was calculated (range 0 to 8) in which higher scores correspond to 
high PA levels (i.e. scores <4 indicate that the person is insufficiently active and scores ≥4 
indicate that the person is sufficiently active) [27]. The Brief PA Assessment Tool has been 
shown to be valid against accelerometers (r=0.53, P<0.001) [28], reliable (k=0.53, P<0.001) 
[27] and feasible for implementation during a single assessment appointment in clinical 
practice [27].  
Age, gender, weight, height, BMI, smoking status and PA were selected as independent 
variables in the equations developed because they are simple to collect in clinical practice and 
have been associated with general exercise capacity [29], or specifically with the 6MWT, 
ISWT or UULEX (e.g. age, gender, weight, height, BMI and PA) [9,10].  
Finally, participants performed two repetitions of one lower limb exercise field test (i.e. 
6MWT or ISWT) and the UULEX, with a 30-minute rest period between them. There was no 
standard order for performing the field tests. Data were collected by trained physiotherapists 
with experience in applying these tests. 
All tests were terminated at  the participant’s request, if abnormal physiological 
responses occurred (i.e. participants reached 90% of their maximum age-predicted heart rate 
[30] or peripheral oxygen saturation was <85%), or if the participant was unable to continue 













dyspnoea, dizziness, leg cramps, diaphoresis and pallor were additional criteria for stopping 
the test. Immediately after finishing each test, distance walked (6MWT and ISWT) or total 
exercise time (UULEX) was recorded. The best performance (i.e. longer distance walked for 
the 6MWT/ISWT and longer exercise time for the UULEX) was used in the analysis. 
 
<B>Six-minute walk test 
The 6MWT was carried out using a 30-m straight walk course, according to the guidelines of 
the American Thoracic Society [32]. The course was marked out on a flat surface, with chairs 
placed at both ends of the course and along the course against the corridor wall. Participants 
were instructed to stand at the zero mark of the walk course, and then walk as fast as possible 
for 6 minutes. Standardised verbal encouragement was given in every minute of the test. 
Participants could stop and rest during the test if necessary, but were instructed to restart 
walking as soon as they were able to do so. The total distance (in m) was recorded. 
 
<B>Incremental shuttle walk test 
The ISWT was performed using a 10-m course identified by two cones placed 0.5 m from each 
end point, according to the test instructions [31]. Participants were instructed to walk (or run) 
around the course according to the speed dictated by an audio signal. The initial walking speed 
was 0.5 m/second and this increased by 0.17 m/second each minute. An adaptation of the 
modified protocol was used as described by Probst et al. [17] to avoid a ceiling effect as 
participants were healthy subjects, hence ensuring their maximal effort. The initial explanation 
was standardised [31], and no verbal encouragement was given to participants during the test. 
The total distance (in m) was recorded. 
 













Participants were instructed to sit on a chair, hold a plastic bar (0.2 kg) and lift it through eight 
levels at a constant cadence of 30 beats per minute, dictated by a metronome [11]. When the 
maximum height was reached, participants received a heavier bar (0.5 kg). Thereafter, the 
weight of the bar was increased by 0.5 kg, to a maximum weight of 2 kg, every minute [11]. 
An adaptation of the protocol [11] (i.e. continuing the cadence until participants stopped, but 
not increasing the weight) was used to avoid a ceiling effect as participants were healthy 
subjects, hence ensuring their maximal effort. The total time (in minutes) was recorded. 
 
<B>Sample size and statistical analysis 
The sample size for multiple linear regression to establish the reference equations was 
determined according to the ‘rule of thumb’ proposed by Green in 1991 [33]: 
𝑁 > 50 + 8𝑚 (1) 
where N is the sample size and m is the number of independent variables. As eight independent 
variables (gender, age, smoking status, PA, height, weight and BMI) were considered in this 
study, a minimum of 114 participants per reference equation formulated were recruited. 
All statistical analyses were performed using SPSS Version 24.0 (IBM Corp., Armonk, 
NY, USA), and plots were created using GraphPad Prism Version 5.01 (GraphPad Software, 
San Diego, CA, USA). The level of statistical significance was set at P<0.05. 
The normality of data distribution was checked using histograms and Q–Q plots. 
Descriptive statistics were used to characterise the sample, and normative values were 
established per gender and age decade using means and 95% confidence intervals. 
Comparisons between age decades and gender (within each age decade) were explored using 
univariate general linear models with Bonferroni’s correction. 
Using a random selection of 70% of the included participants, reference equations were 













univariate correlation coefficients (r) were computed to examine the association between each 
of the dependent variables (i.e. 6MWT distance, ISWT distance and UULEX time) and the 
independent variables (age, gender, weight, height, BMI, smoking status and PA). The 
dependent variables that were significantly correlated with each of the independent variables 
were fitted in a forward selection stepwise multiple regression. The assumptions of the multiple 
regression were confirmed (i.e. linear relationship between dependent and independent 
variables, absence of multicollinearity within the independent variables, homoscedasticity, 
outliers and normality of residuals), and R2 was used to assess the performance of each model. 
The performance and reliability of each developed equation were further assessed with the 
remaining 30% of the sample. This sample size was established in accordance with recent 
literature, in which tests of the reference equations are conducted in samples of 8% to 40% 
[14,17,34,35]. This analysis consisted of comparing (one-way analysis of variance), and testing 
for absolute reliability (Bland and Altman plots) [36–38], the results obtained with each new 
equation with previous existing reference equations. Similar analysis was then conducted 
comparing the results from the new equations with the actual values achieved by 30% of the 
sample. The criteria for selecting equations for comparison were based on geographical 
proximity, ease of implementation in clinical practice, variance explained and general 
acceptability by the scientific community (i.e. citations in scientific papers). Thus, the reference 
equations proposed by Enright et al. [39] for the 6MWT and by Probst et al. [39] for the ISWT 
were used for comparison purposes. 
No comparison equation was used for the UULEX as this was the first study to develop a 















In total, 563 adults participated in the study {44% male, mean age 53 [standard deviation (SD) 
25] (range 18 to 97) years, mean BMI 26 (SD 5) kg/m2}. Most were non-smokers (n=446, 
79%), insufficiently active (n=372, 66%) and, according to the CCI, presented no (n=244, 43%) 
or one to two (n=105, 19%) comorbidities. All participants performed the UULEX plus one 
lower limb exercise field test. However, 26 participants only performed the UULEX due to use 
of walking aids, and 18 participants only agreed to performed one field test (11 performed the 
UULEX, five performed the 6MWT and two performed the ISWT). The reasons for test 
selection were participants’ time constrains and personal preferences. Thus, 298 subjects 
completed the 6MWT [39% male, mean age 52 (SD 24) years, mean BMI 26 (5) kg/m2], 228 
subjects completed the ISWT [51% male, mean age 51 (SD 24) years, mean BMI 26 (SD 5) 
kg/m2], and 556 subjects completed the UULEX [43% male, mean age 54 (SD 25) years, mean 
BMI 26 (SD 5) kg/m2]. Participants’ characteristics are shown in Table 1. 
 
<insert Table 1 near here> 
 
<B>Normative values 
Table 2 shows the normative values for the 6MWT, ISWT and UULEX for each age decade 
and gender. Participants walked a mean distance of 524 (SD 208) m in the 6MWT and 843 (SD 
568) m in the ISWT, and took 10.4 (SD 4.9) minutes to perform the UULEX. Generally, 
performance in cardiorespiratory field tests was found to decrease with age. Significantly 
poorer performances in the ISWT emerged after the fifth decade of life, whilst for the 6MWT 
and the UULEX, poorer performances were presented after the sixth decade of life (P<0.001).  
Gender differences within each age decade were observed mainly for the ISWT and 













decade of life (P<0.05). In the ISWT, males walked significantly further than females (P<0.05) 
in almost every age decade, except for the fifth, seventh and eighth decades of life. Finally, for 
the UULEX, males performed significantly better than females, especially from the fourth 
decade of life onwards (P<0.05), but also in the second decade of life (P<0.001). Exact P-
values for multiple comparisons can be found in the online supplementary material. 
 
<insert Table 2 near here> 
 
<B>Reference equations 
<C>Six-minute walk test 
The best performance in the 6MWT of 208 (70% of 298) participants [42% male, mean age 53 
(SD 24) years, mean BMI 26 (SD 5) kg/m2] was used to compute the reference equation. There 
were significant correlations between distance walked in the 6MWT and gender (r=0.23, 
P=0.003), age (r=-0.82, P<0.001), smoking status (r=0.14, P=0.04), PA (r=0.27, P<0.001), 
height (r=0.59, P<0.001) and BMI (r=-0.44, P<0.001), but not with weight (r=-0.001, P=0.98). 
A model of stepwise multiple regression showed that age and height explained 71% (P<0.001) 
of variability in the 6MWT. Age had the strongest (β=-0.70 vs β=0.24 for height) relationship 
with the 6MWT (Table 3). The reference equation for distance walked in the 6MWT was: 
 
6𝑀𝑊𝑇𝑝𝑟𝑒𝑑 = 226.93 − (5.00 × 𝑎𝑔𝑒𝑦𝑒𝑎𝑟𝑠) + (360.41 × ℎ𝑒𝑖𝑔ℎ𝑡𝑚) (2) 
 
Reliability of Equation (2) was tested in 90 (30% of 298) participants. Analysis of the 
Bland and Altman plots dictated the removal of four outliers, so 86 participants were analysed 
[33% male, mean age 53 (SD 24) years, mean BMI 26 (SD 5) kg/m2]. No significant differences 













Equation (2) or by the equation of Enright et al. [39] (P=0.67). No systematic bias was observed 
between values achieved by participants and those predicted by any of the equations (Fig. 1). 
 
<insert Fig 1 near here> 
 
<C>Incremental shuttle walk test 
The best performance in the ISWT of 159 (70% of 228) participants [49% male, mean age 51 
(SD 25) years, mean BMI 26 (SD 5) kg/m2] was used to compute the reference equation. There 
were significant correlations between distance walked in the ISWT and gender (r=0.30, 
P<0.001), age (r=-0.87, P<0.001), PA (r=0.38, P<0.001), height (r=0.66, P<0.001) and BMI 
(r=-0.50, P<0.001), but not with smoking status (r=0.01, P=0.94) and weight (r=-0.02, 
P=0.79). A model of stepwise multiple regression showed that age, gender and height 
explained 83% (P<0.001) of variability in the ISWT. Age had the strongest (β=-0.79 vs β=0.17 
for gender vs β=0.15 for height) relationship with the ISWT (Table 3). The reference equation 
for distance walked in the ISWT was: 
 
𝐼𝑆𝑊𝑇𝑝𝑟𝑒𝑑 = 393.81 − (17.98 × 𝑎𝑔𝑒𝑦𝑒𝑎𝑟𝑠) + (185.64 × 𝑔𝑒𝑛𝑑𝑒𝑟)  + (775.88 × ℎ𝑒𝑖𝑔ℎ𝑡𝑚) 
(3) 
 
where female=0 and male=1. 
Reliability of Equation (3) was tested in 69 (30% of 228) participants. Analysis of the 
Bland and Altman plots dictated the removal of four outliers, so 65 participants were analysed 
[52% male, mean age 52 (SD 24) years, mean BMI 27 (SD 5) kg/m2]. No significant differences 
were observed between the actual values achieved by participants and the values predicted by 













between values achieved by participants and those predicted by Equation (3) (Fig. 2A). 
However, systematic bias was observed using the equation proposed by Probst et al. [17], i.e. 
a significant overestimation of lower scores and underestimation of higher scores was observed 
(Fig. 2B). 
 
<insert Fig 2 near here> 
 
<C>Unsupported upper limb exercise test 
The best performance in the UULEX of 389 (70% of 556) participants [43% male, mean age 
54 (SD 25) years, mean BMI 27 (SD 5) kg/m2] was used to compute the reference equation. 
There were significant correlations between the duration of performance in the UULEX and 
gender (r=0.34, P<0.001), age (r=-0.71, P<0.001), smoking status (r=0.14, P=0.004), PA 
(r=0.35, P<0.001), height (r=0.59, P<0.001) and BMI (r=-0.35, P<0.001), but not with weight 
(r=-0.09, P=0.08). A model of stepwise multiple regression showed that age and gender 
explained 57% (P<0.001) of variability in the UULEX. Age had the strongest (β=-0.68 vs 
β=0.26 for gender) relationship with the UULEX (Table 3). The reference equation for distance 
walked in the UULEX was: 
 
𝑈𝑈𝐿𝐸𝑋𝑝𝑟𝑒𝑑 = 16.71 − (0.14 × 𝑎𝑔𝑒𝑦𝑒𝑎𝑟𝑠) + (2.66 × 𝑔𝑒𝑛𝑑𝑒𝑟) (4) 
where female=0 and male=1. 
Reliability of Equation (4) was tested in 167 (30% of 556) participants. Analysis of the 
Bland and Altman plots dictated the removal of four outliers, so 163 participants were analysed 
[43% male, mean age 54 (SD 25) years, mean BMI 26 (SD 5) kg/m2]. No significant differences 













Equation (4) (P=0.46). No systematic bias was observed between values achieved by 
participants and those predicted by Equation (4) (Fig. 3). 
 
<insert Fig 3 and Table 3 near here> 
 
<A>Discussion 
This study showed that gender and age significantly affect performance in cardiorespiratory 
field tests, especially after the sixth decade of life, with males and young people generally 
presenting better performances. Variability in reference equations developed for the 6MWT, 
ISWT and UULEX was mainly explained by age. 
Few studies exist that include intervals of age wide enough to compute normative 
values of field tests for age decades [20,40]. Nevertheless, age has been indicated as a powerful 
predictor of performance in exercise field tests [41], and previous authors have shown a marked 
decline in the 6MWT after the fifth or sixth decade of life [20,40]. This study supports these 
findings and adds to the body of knowledge that a similar pattern is also present in other 
cardiorespiratory field tests, such as the ISWT and UULEX. 
Similar to age, gender has been considered as a powerful predictor of CRF [42]. In this 
study, differences between genders, according to age decade, were mainly present in the ISWT 
and UULEX, rather than in the 6MWT. Additionally, gender was not included as a predictor 
in the 6MWT reference equation [Equation (2)]. The absence of gender as a predictor of 
distance walked in the 6MWT has been reported previously [34,43], as it has been found that 
after correcting for height, males do not walk further than females [39]. The normative values 
in this study did not take height into account; therefore, mean differences of approximately 40 
m between genders were observed in all age decades, which exceeds the established minimal 













differences between genders among age decades, the clinically relevant differences found 
demand that normative values per gender are confirmed when interpreting patients’ 
performance in CRF tests.  
The equations developed for the 6MWT and ISWT [Equations (2) and (3)] were 
compared with those from Enright et al. [39] and Probst et al. [17], and no significant 
differences were observed between the predicted values. Nevertheless, in contrast to the 
previous equations, systematic bias was not observed, limits of agreement were narrower and 
larger variability was explained by Equation (2) for the 6MWT (73% vs 32% for male and 48% 
for female [39]) and Equation (3) for the ISWT (84% vs 71% [17]). Similar to previous studies 
[17,35,45], these discrepancies between equations may be attributed to population differences 
between samples, as the subjects in the present study were slightly taller than those in the study 
by Probst et al. [17], and significantly shorter than those enrolled by Enright et al. [39]. These 
results illustrate the errors that could arise from using equations that were not developed 
specifically for the population being assessed, and highlight the importance of developing 
population-specific reference equations, supporting the recommendations of the European 
Respiratory Society and the American Thoracic Society [8]. 
Regarding the UULEX, similar to walking tests and previous research [9], participants 
over 50 years of age performed significantly worse than younger people. Evidence suggests 
that the aging process can decrease muscular functional performance, leading to worse 
performance of daily living activities involving the upper limbs [46]. Nevertheless, the amount 
of variability explained for the UULEX (59%) was much lower than the amount of variability 
explained for the walking tests (73% and 84%), meaning that the variables assessed may not 
be adequate to explain variability in the UULEX. It is known that upper limb exercise 













limb muscle strength might be a good indicator of performance in the UULEX. Future studies 
should be performed to verify this hypothesis. 
To the authors’ knowledge, this is the first study to develop reference equations for 
three CRF field tests for the Portuguese adult population. Given the population specificity of 
reference equations and normative data [10], and the discrepancies found between this study 
and previous equations, it is suggested that the equations developed should be preferred to 
those reported previously. Additionally, all three equations were developed using a wide age 
range (18 to 97 years) and gender representative samples, and only include easy-to-acquire 
anthropometric and/or demographic data, facilitating their direct translation to everyday 
clinical practice of health professionals. These equations and normative values will allow for 
more appropriate evaluation and interpretation of the exercise capacity of patients with chronic 
diseases, guiding personalised and tailored interventions involving exercise prescription. 
 
<B>Study limitations 
This study has some limitations that need to be acknowledged. Firstly, the use of a convenience 
sample might have affected the results. Although this methodology has been adopted by most 
studies in this area [16,17,39,49], efforts were made to recruit participants from different 
settings, geographical locations, educational levels and economic activities across the country 
to obtain a representative sample. It is believed that this limitation was minimised by also 
assessing the reliability of the equations proposed through prospective assessment in a 
randomly selected, similar sample of participants. Secondly, the order of tests was not 
randomised, but was performed according to the participants’ preference. Although local 
fatigue was avoided by assuring that participants only performed an upper and/or one of the 
two lower exercise field tests, with a 30-minute rest period between tests, generalised fatigue 













of agreement between the equations developed for the 6MWT and ISWT [Equations (2) and 
(3)] and the actual values achieved by participants can be interpreted as being wide (i.e. above 
or below more than 100 m), which could somewhat affect the validity of equations. 
Nevertheless, the equations developed in this study still present narrower limits of agreement 
and lower bias than the equations tested, and thus the equations developed in this study should 
be preferred when assessing Portuguese patients. Fourthly, comorbidities were self-reported, 
as assessed with the CCI, and could not be confirmed by medical records. To minimise this 
limitation, a detailed assessment of all study participants was performed to ensure that those 
presenting with comorbidities that could affect the outcomes of the study were not included. 
Finally, regarding the UULEX, other variables which could also have a role in explaining the 
variance in this test were not assessed, such as upper limb peripheral muscle strength.  
 
<A>Conclusion 
Gender and age significantly affect performance in the 6MWT, ISWT and UULEX, especially 
after the sixth decade of life, with males and young people generally achieving better results 
than females and older people. Age was a determinant variable for the reference equations of 
all exercise field tests. These results will help health professionals to detect people with lower 
CRF and develop adequate exercise prescription in diseased populations, according to the best 
recommendations from international societies. Nevertheless, the findings from this study 
should only be considered when using the same testing protocol in order to avoid 
misinterpretation of the reference values and/or equations. 
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Contribution of the paper 
Key messages of the article 
 Lower and upper limb exercise field tests are affected significantly by age and gender. 
 Participants’ performance on exercise tests is significantly reduced after the sixth decade of 
life. 
New knowledge added by this study 
 Reference equations for the Portuguese population were developed for the 6-minute walk test 
[226.93-(5.00×age)+(360.41×height)] and the incremental shuttle walk test [393.81-
(17.98×age)+(185.64×gender)+(775.88×height)],  
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Fig. 1. Bland and Altman plots of the difference between (A) the predicted (with the developed 
equation) and actual values of the 6-minute walk test (6MWT) plotted against the mean of the 
predicted (with the developed equation) and actual values of the 6MWT; and (B) the predicted 
(with Enright et al. equation) and actual values of the 6MWT plotted against the mean of the 
predicted (with Enright et al. equation) and actual values of the 6MWT. ULA, upper limit of 
agreement; LLA, lower limit of agreement. 
 
Fig. 2. Bland and Altman plots of the difference between (A) the predicted (with the developed 
equation) and actual values of the incremental shuttle walk test (ISWT) plotted against the 
mean of the predicted (with the developed equation) and actual values of the ISWT; and (B) 
the predicted (with Probst et al. equation) and actual values of the ISWT plotted against the 
mean of the predicted (with Probst et al. equation) and actual values of the ISWT. ULA, upper 














Fig. 3. Bland and Altman plots of the difference between the predicted and actual values of the 
unsupported upper limb exercise test (UULEX) plotted against the mean of the predicted and 
















Characteristics of participants (n=563) 








Age, years, mean (SD) 53 (25) 52 (24) 51 (24) 54 (25) 
Gender (male), n (%) 245 (44) 115 (39) 116 (51) 241 (43) 
Height, m, mean (SD) 1.63 (0.11) 1.63 (0.11) 1.66 (0.11) 1.64 (0.11) 
Weight, kg, mean (SD) 70 (14) 70 (15) 71 (13) 70 (14) 
BMI, kg/m2, mean (SD) 26 (5) 26 (5) 26 (5) 26 (5) 
Smoking status, n (%)     
Current smokers 77 (14) 45 (15) 30 (13) 73 (13) 
Past smokers 38 (7) 20 (7) 17 (8) 38 (7) 
Never smokers 448 (80) 233 (78) 181 (79) 445 (80) 
CCI, categories     
0 244 (43) 123 (44) 111 (49) 241 (43) 
1–2 105 (19) 62 (21) 41 (18) 103 (19) 
3–4 158 (28) 71 (24) 63 (28) 157 (28) 
≥5 56 (10) 33 (11) 13 (6) 55 (10) 
Physical activity (score 0–8), 
median (IQR) 
3 (1–4) 3 (1–4) 3 (1–4) 3 (1–4) 
Sufficiently active (≥4), n 
(%) 
191 (34) 95 (32) 87 (38) 154 (35) 
6MWT, 6-minute walk test; BMI, body mass index; ISWT, incremental shuttle walk test; 
UULEX, unsupported upper limb exercise test; CCI, Charlson Comorbidity Index; SD, 













 Table 2 
Normative values [mean (range)] for cardiorespiratory field tests by age decade and gender 
 
  Age groups (years) 



















































































































































































































6MWT, 6-minute walk test; ISWT, incremental shuttle walk test; UULEX, unsupported 
upper limb exercise test.  
Statistical differences (P<0.05) were identified using the following symbols:  
aDifferent from all age groups.   
bDifferent from all age groups, except 60–69 and 70–79 years. 
cDifferent from all age groups, except 18–29, 30–39 and 40–49 years. 
dDifferent from all age groups, except 30–39 and 40–49 years. 






































Multiple linear regression analysis with 6-minute walk test (6MWT), incremental shuttle walk 
test (ISWT) and unsupported upper limb exercise test (UULEX) as dependent variables 




   




6MWT 0.7       
Constant  226.9 120.5  -10.6 to 
464.6 
 93.3 
Age  -5.0 0.3 -0.7 -5.6 to -
4.4 
<0.001 
Height  360.4 67.8 0.2 226.6 to 
494.2 
<0.001 
ISWT 0.8       




Age  -18.0 1.0 -0.8 -19.9 to 
-16.1 
<0.001 
Gender  185.6 54.5 0.2 78.0 to 
293.2 
0.001 
Height  775.9 281.2 0.2 220.3 to 
1331.5 
0.007 













Constant  16.7 0.4   15.8 to 
17.6 
  
Age  -0.1 0.0 -0.68 -0.2 to -
0.1 
<0.001 
Gender  2.7 0.3 0.26 2.0 to 
3.3 
<0.001 
BMI, body mass index; CI, confidence interval; PA, physical activity; B, unstandardised 
coefficients; β, beta (standardised coefficient); SE, standard error. 
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